The Biotechnology Development Headquarters in the Vice Presidency of Science and Technology is trying to develop the export of bio-based products in international markets by establishing foreign specialized offices in other countries. It is expected that 7 specialized offices will be established by the end of this year.

Currently, 2 specialized offices have been established in Malaysia and Kenya. These countries have a high good economic and social capacity, and since Malaysia is one of the countries that adhere to international standards, the registration and sale of the product in this country will be the sales gateway to all countries in the ASEAN region.

Therefore, one of the priorities of the Biotechnology Development Headquarters in the Vice Presidency of Science and Technology is to develop the Iranian market of pharmaceutical technologies and medical equipment in this country. It also has good potential for developing markets for tissue culture, supplements and probiotics, and livestock and poultry vaccines, and can help knowledge-based companies develop international products and services.

Accordingly, the Biotechnology Development Headquarters in the Vice Presidency of Science and Technology has conducted a thorough and detailed study of the market of biotechnology and pharmaceutical products in Malaysia  to implement this work in the first phase after completing the manpower team in Malaysia.

This work will continue with the beginning of the process of registering pharmaceutical and biological products, including probiotics. Other next steps include "preparing the infrastructure for a virtual exhibition of Iranian biotechnology products" and "negotiating and planning for the branding of biotechnology products in that country."

Communication and Information Center in the Vice Presidency of Science and Technology